http://rdf.ncbi.nlm.nih.gov/pubchem/reference/6157065

Outgoing Links

Predicate Object
contentType Journal Article|Multicenter Study|Randomized Controlled Trial|Research Support, Non-U.S. Gov't
endingPage 751
issn 1476-0584
1744-8395
issueIdentifier 6
pageRange 743-751
publicationName Expert Review of Vaccines
startingPage 743
hasFundingAgency http://rdf.ncbi.nlm.nih.gov/pubchem/organization/MD5_e8559e7f08327056a10610fb69135d0d
bibliographicCitation Feng Y, Yao T, Han Y, Shi J, Dong S, Wu Y, Shao Z, Liu H, Guo H, Chai G, Liu L, Wang F, Wang J, Liang X, Wang S. Immunogenicity and safety of a high-dose and prolonged-schedule hepatitis B vaccine among chronic kidney disease patients: a randomized, parallel-controlled trial. Expert Rev Vaccines. 2021 Jun;20(6):743–51. doi: 10.1080/14760584.2021.1915777. PMID: 34058948.
creator http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_acb4efbc393dea61c6740debaa391957
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_12bf25edc436e4b8260358e83754bd19
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9eeb5dd5d5e0735a34968c3bc47fd516
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_affd4c7e20416ce564055dc60a02a37b
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_fec9b294fd3f687748853f7cef6be836
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_0684bb089084461490a8c5322a48904f
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_9b39d992686cabb550afbdbef87b592c
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_ebc16479d09e8be26d04eb34b6c756c9
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7cb7fd2266b80b6e5a4d7856a0bbe914
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_62afa58973c4718da2855c89e9dbd2f4
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7e285d15806f1262ceeb5dd753ee670e
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_2aae5a091ef7a09a2830fc4c8c600d11
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_cd0b564a18775cbf06a88f327aaba9a3
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_d536741f7c23968231a2edc0e1d00750
http://rdf.ncbi.nlm.nih.gov/pubchem/author/MD5_7593e43a3a495829d99f67c7b13da66f
date 2021-05-31^^<http://www.w3.org/2001/XMLSchema#date>
identifier https://pubmed.ncbi.nlm.nih.gov/34058948
https://doi.org/10.1080/14760584.2021.1915777
isPartOf https://portal.issn.org/resource/ISSN/1744-8395
http://rdf.ncbi.nlm.nih.gov/pubchem/journal/30416
https://portal.issn.org/resource/ISSN/1476-0584
language English
source https://www.crossref.org/
https://pubmed.ncbi.nlm.nih.gov/
title Immunogenicity and safety of a high-dose and prolonged-schedule hepatitis B vaccine among chronic kidney disease patients: a randomized, parallel-controlled trial
discusses http://id.nlm.nih.gov/mesh/M0026310
http://id.nlm.nih.gov/mesh/M0010211
hasPrimarySubjectTerm http://id.nlm.nih.gov/mesh/D051436
http://id.nlm.nih.gov/mesh/D006509Q000517
hasSubjectTerm http://id.nlm.nih.gov/mesh/D000069078
http://id.nlm.nih.gov/mesh/D000071497
http://id.nlm.nih.gov/mesh/D006801
http://id.nlm.nih.gov/mesh/D017325
http://id.nlm.nih.gov/mesh/D006510
discussesAsDerivedByTextMining http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID10922
http://rdf.ncbi.nlm.nih.gov/pubchem/disease/DZID7989

Showing number of triples: 1 to 46 of 46.